Vivo Capital, LLC

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 40Value: $755.1MLatest: 2025Q1

Vivo Capital, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 40 holdings worth $0.8 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AKRO",
  "TRVI",
  "ORIC",
  "TIL",
  "AVDL",
  "ATXS",
  "OLMA",
  "SLN",
  "TERN",
  "TRML",
  "ABEO",
  "ALGS",
  "ALLK",
  "BOLT",
  null,
  "GERN",
  "SRZN",
  "UNCY",
  "ZBIO",
  "RZLT",
  "ACRS",
  "SERA",
  "DTIL",
  "TENX",
  "RGLS",
  "SLNO",
  "COGT",
  "ETNB",
  "DYN",
  "CMPS",
  "CRVS",
  "CDTX",
  "ERAS",
  "DCTH",
  "IOBT",
  "VRNA",
  "VSTM",
  "VRDN",
  "CELC",
  "CMPX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-12
Total Holdings: 40
Total Value: 755066478
Accession Number: 0001213900-25-041737
Form Type: 13F-HR
CIK: vivo-capital
Manager Name: Vivo-Capital

Data Enrichment

98% identified

39 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

40 positions • $755.1M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:4.5M

Value:$318.5M

% of Portfolio:42.2% ($318.5M/$755.1M)

Verona Pharma plc

VRNA|925050106

Shares:1.4M

Value:$91.3M

% of Portfolio:12.1% ($91.3M/$755.1M)

GERON CORP

GERN|374163103

Shares:27.2M

Value:$43.3M

% of Portfolio:5.7% ($43.3M/$755.1M)

Trevi Therapeutics, Inc.

TRVI|89532M101

Shares:3.5M

Value:$21.9M

% of Portfolio:2.9% ($21.9M/$755.1M)

AVADEL PHARMACEUTICALS PLC

AVDL|G29687103

Shares:2.7M

Value:$21.0M

% of Portfolio:2.8% ($21.0M/$755.1M)

Terns Pharmaceuticals, Inc.

TERN|880881107

Shares:6.9M

Value:$19.0M

% of Portfolio:2.5% ($19.0M/$755.1M)

Cidara Therapeutics, Inc.

CDTX|171757206

Shares:684.3K

Value:$14.7M

% of Portfolio:2.0% ($14.7M/$755.1M)

Aclaris Therapeutics, Inc.

ACRS|00461U105

Shares:8.9M

Value:$13.6M

% of Portfolio:1.8% ($13.6M/$755.1M)

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:982.6K

Value:$13.2M

% of Portfolio:1.8% ($13.2M/$755.1M)

Dyne Therapeutics, Inc.

DYN|26818M108

Shares:1.1M

Value:$11.7M

% of Portfolio:1.5% ($11.7M/$755.1M)

Oric Pharmaceuticals, Inc.

ORIC|68622P109

Shares:2.1M

Value:$11.6M

% of Portfolio:1.5% ($11.6M/$755.1M)

Instil Bio, Inc.

TIL|45783C200

Shares:585.5K

Value:$10.2M

% of Portfolio:1.3% ($10.2M/$755.1M)

COMPASS Pathways plc

CMPS|20451W101

Shares:3.4M

Value:$9.6M

% of Portfolio:1.3% ($9.6M/$755.1M)

DELCATH SYSTEMS, INC.

DCTH|24661P807

Shares:750.2K

Value:$9.5M

% of Portfolio:1.3% ($9.5M/$755.1M)

Zenas BioPharma, Inc.

ZBIO|98937L105

Shares:1.2M

Value:$9.3M

% of Portfolio:1.2% ($9.3M/$755.1M)

Verastem, Inc.

VSTM|92337C203

Shares:1.5M

Value:$9.3M

% of Portfolio:1.2% ($9.3M/$755.1M)

Erasca, Inc.

ERAS|29479A108

Shares:6.8M

Value:$9.3M

% of Portfolio:1.2% ($9.3M/$755.1M)

10919W405

Shares:251.6K

Value:$9.1M

% of Portfolio:1.2% ($9.1M/$755.1M)

Tourmaline Bio, Inc.

TRML|89157D105

Shares:591.9K

Value:$9.0M

% of Portfolio:1.2% ($9.0M/$755.1M)

ABEONA THERAPEUTICS INC.

ABEO|00289Y206

Shares:1.8M

Value:$8.8M

% of Portfolio:1.2% ($8.8M/$755.1M)

Instrument	Shares		Other Manager	Value	% of Portfolio
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	4.5M	QoQ -29.14% (-1.8M) YoY -47.03% (-4.0M)	All Managers (Combined)	$318.5M	42.2% ($318.5M/$755.1M)	QoQ +12.63% (-$35.7M) YoY -11.58% (-$41.7M)
Verona Pharma plc(VRNAcusip925050106)	1.4M	QoQ -37.00% (-845.2K) YoY -60.14% (-2.2M)	All Managers (Combined)	$91.3M	12.1% ($91.3M/$755.1M)	QoQ -13.87% (-$14.7M) YoY +57.25% (-$33.3M)
GERON CORP(GERNcusip374163103)	27.2M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$43.3M	5.7% ($43.3M/$755.1M)	QoQ -55.08% (-$53.1M) YoY -51.81% (-$46.6M)
Trevi Therapeutics, Inc.(TRVIcusip89532M101)	3.5M	QoQ 0.00% (+0) YoY NEW(+3.5M)	All Managers (Combined)	$21.9M	2.9% ($21.9M/$755.1M)	QoQ +52.66% (+$7.6M) YoY NEW(+$21.9M)
AVADEL PHARMACEUTICALS PLC(AVDLcusipG29687103)	2.7M	QoQ 0.00% (-0) YoY NEW(+2.7M)	All Managers (Combined)	$21.0M	2.8% ($21.0M/$755.1M)	QoQ -25.49% (-$7.2M) YoY NEW(+$21.0M)
Terns Pharmaceuticals, Inc.(TERNcusip880881107)	6.9M	QoQ 0.00% (-0) YoY +3.57% (-237.8K)	All Managers (Combined)	$19.0M	2.5% ($19.0M/$755.1M)	QoQ -50.18% (-$19.2M) YoY -56.42% (-$24.6M)
Cidara Therapeutics, Inc.(CDTXcusip171757206)	684.3K	QoQ +2.03% (-13.7K) YoY NEW(+684.3K)	All Managers (Combined)	$14.7M	2.0% ($14.7M/$755.1M)	QoQ -18.23% (-$3.3M) YoY NEW(+$14.7M)
Aclaris Therapeutics, Inc.(ACRScusip00461U105)	8.9M	QoQ 0.00% (-0) YoY NEW(+8.9M)	All Managers (Combined)	$13.6M	1.8% ($13.6M/$755.1M)	QoQ -38.30% (-$8.4M) YoY NEW(+$13.6M)
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	982.6K	QoQ 0.00% (-0) YoY -41.45% (-695.6K)	All Managers (Combined)	$13.2M	1.8% ($13.2M/$755.1M)	QoQ -29.68% (-$5.6M) YoY -54.92% (-$16.1M)
Dyne Therapeutics, Inc.(DYNcusip26818M108)	1.1M	QoQ 0.00% (-0) YoY -31.81% (-520.2K)	All Managers (Combined)	$11.7M	1.5% ($11.7M/$755.1M)	QoQ -55.60% (-$14.6M) YoY -74.87% (-$34.8M)
Oric Pharmaceuticals, Inc.(ORICcusip68622P109)	2.1M	QoQ +62.81% (+802.6K) YoY +144.85% (-1.2M)	All Managers (Combined)	$11.6M	1.5% ($11.6M/$755.1M)	QoQ +12.57% (+$1.3M) YoY -0.63% (-$74.2K)
Instil Bio, Inc.(TILcusip45783C200)	585.5K	QoQ 0.00% (-0) YoY -6.22% (-38.9K)	All Managers (Combined)	$10.2M	1.3% ($10.2M/$755.1M)	QoQ -9.06% (-$1.0M) YoY +50.73% (-$3.4M)
COMPASS Pathways plc(CMPScusip20451W101)	3.4M	QoQ +109.10% (+1.8M) YoY +109.10% (-1.8M)	All Managers (Combined)	$9.6M	1.3% ($9.6M/$755.1M)	QoQ +58.21% (+$3.5M) YoY -28.12% (-$3.8M)
DELCATH SYSTEMS, INC.(DCTHcusip24661P807)	750.2K	QoQ -56.09% (-958.4K) YoY -54.99% (-916.6K)	All Managers (Combined)	$9.5M	1.3% ($9.5M/$755.1M)	QoQ -53.57% (-$11.0M) YoY +20.11% (-$1.6M)
Zenas BioPharma, Inc.(ZBIOcusip98937L105)	1.2M	QoQ 0.00% (-0) YoY NEW(+1.2M)	All Managers (Combined)	$9.3M	1.2% ($9.3M/$755.1M)	QoQ -3.54% (-$343.1K) YoY NEW(+$9.3M)
Verastem, Inc.(VSTMcusip92337C203)	1.5M	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$9.3M	1.2% ($9.3M/$755.1M)	QoQ +16.63% (+$1.3M) YoY -48.89% (-$8.9M)
Erasca, Inc.(ERAScusip29479A108)	6.8M	QoQ 0.00% (-0) YoY NEW(+6.8M)	All Managers (Combined)	$9.3M	1.2% ($9.3M/$755.1M)	QoQ -45.41% (-$7.7M) YoY NEW(+$9.3M)
(cusip10919W405)✕	251.6K	QoQ 0.00% (+0) YoY NEW(+251.6K)	All Managers (Combined)	$9.1M	1.2% ($9.1M/$755.1M)	QoQ +0.13% (+$12.6K) YoY NEW(+$9.1M)
Tourmaline Bio, Inc.(TRMLcusip89157D105)	591.9K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$9.0M	1.2% ($9.0M/$755.1M)	QoQ -25.00% (-$3.0M) YoY -33.58% (-$4.6M)
ABEONA THERAPEUTICS INC.(ABEOcusip00289Y206)	1.8M	QoQ 0.00% (-0) YoY NEW(+1.8M)	All Managers (Combined)	$8.8M	1.2% ($8.8M/$755.1M)	QoQ -14.54% (-$1.5M) YoY NEW(+$8.8M)